Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001301120-25-000030

Chief Scientific Officer sold 3,555 shares at $3.24 ($11,520)

  • Chief Scientific Officer acquired 3,555 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moreadith Randall · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-11 Exercise or conversion : show line 1 in the form 10b5-1 +3,555 $0.06 $213 3,555 D
2025-12-11 Sale : show line 2 in the form 10b5-1 −3,555 $3.24 $11,520 0 D
Open-market sales · 3,555 sh · avg $3.24 · $11,520

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-11 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −3,555 366,886 D
Loading xslF345X05/wk-form4_1765561686.xml…